American Society of Hirudotherapy

Hirudotherapy - a rare cause of pseudolymphoma

Research article published in Postepy dermatologii i alergologii (2018)

Last Updated: March 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Clinical TrialsTupikowska M et al. · Postepy dermatologii i alergologii, 2018

Summary

Hirudotherapy - a rare cause of pseudolymphoma.

Why This Matters for Hirudotherapy

Contributes clinical evidence for the therapeutic application of leech therapy.

Citation

Hirudotherapy - a rare cause of pseudolymphoma.

Tupikowska M et al. · Postepy dermatologii i alergologii, 2018

Added to ASH library: March 18, 2026 · Site last updated: March 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.

Hirudotherapy - a rare cause of pseudolymphoma | ASH